BioXcel Therapeutics (BTAI) Non-cash Items (2017 - 2026)

BioXcel Therapeutics' Non-cash Items history runs 10 years deep, the most recent figure standing at $409000.0 for Q1 2026.

• In Q1 2026, Non-cash Items fell 75.58% year-over-year to $409000.0; the TTM figure through Mar 2026 stood at $409000.0 (down 75.58% YoY), while the FY2025 annual figure was $328000.0, up 31.73% from the prior year.
• Non-cash Items was $409000.0 for Q1 2026 at BioXcel Therapeutics, up from $328000.0 in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $22.8 million in Q1 2022 to a low of $249000.0 in Q4 2024.
• Historically, Non-cash Items has averaged $4.7 million across 5 years, with a median of $3.0 million in 2022.
• Biggest YoY gain for Non-cash Items was 592.53% in 2022; the steepest drop was 95.29% in 2022.
• A 5-year view of Non-cash Items shows it stood at $3.0 million in 2022, then advanced by 15.89% to $3.5 million in 2023, then plunged by 92.84% to $249000.0 in 2024, then jumped by 31.73% to $328000.0 in 2025, then climbed by 24.7% to $409000.0 in 2026.
• The last three Non-cash Items figures came in at $409000.0 (Q1 2026), $328000.0 (Q4 2025), and $306000.0 (Q3 2025), per Business Quant data.